SEC Form 4 research
| Issuer | Scribe Therapeutics, Inc. |
|---|---|
| Tickers | SCTX |
| Reporting owners | 20 |
| Officers and directors | 7 |
| Last public filing | 2026-07-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-07-29 | 2026-07-27 | AH Bio Fund II, L.P., AH Bio Fund III, L.P., AH Equity Partners Bio II, L.L.C., AH Equity Partners Bio III, L.L.C., Andreessen Marc L, HOROWITZ BENJAMIN A | P | 333,333 | $15 | Not reported |
| 2026-07-29 | 2026-07-27 | GORDON CARL L | P | 1,000,000 | $15 | Not reported |
| 2026-07-29 | 2026-07-27 | ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC | P | 1,000,000 | $15 | Not reported |
| 2026-07-28 | 2026-07-23 | Staahl Brett | A | 19,385 | $0 | Not reported |
| 2026-07-28 | 2026-07-23 | Staahl Brett | A | 19,385 | $0 | Not reported |
| 2026-07-28 | 2026-03-13 | Staahl Brett | A | 4,755 | $0 | Not reported |
| 2026-07-28 | 2026-07-28 | Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLC | P | 7,905 | $18.25 | Not reported |
| 2026-07-28 | 2026-07-24 | Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLC | P | 50,000 | $22.31 | Not reported |
| 2026-07-28 | 2026-07-24 | Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLC | P | 2,333,333 | $15 | Not reported |
| 2026-07-27 | 2026-07-23 | Watson James Dean | A | 14,725 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.